Ineffectiveness of myrrh-derivative Mirazid against schistosomiasis and fascioliasis in humans
EMHJ-Eastern Mediterranean Health Journal. 2010; 16 (9): 932-936
Dans Anglais
| IMEMR
| ID: emr-158523
ABSTRACT
The present study assessed the schistosomicidal and fasciolicidal actions of the myrrh-derivative Mirazid in an area of low schistosomiasis transmission. A total of 27 patients infected with Schistosoma mansoni and 16 with Fasciola spp. received the maximum recommended dose of Mirazid. Pretreatment egg counts in 4 Kato-Katz slides were compared with similar counts in stool samples collected 1 and 2 months after treatment. Standard procedures and quality control measures were followed. The results revealed that Mirazid used as schistosomicidal or fasciolicidal agent in the maximum recommended dose has a low cure rate and produced a negligible reduction in egg counts. Prescribing such an ineffective drug in Egypt might endanger the achievements of the schistosomiasis control strategy
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Extraits de plantes
/
Résultat thérapeutique
/
Fasciolase
Limites du sujet:
Adolescent
/
Adulte
/
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
East Mediterr Health J.
Année:
2010
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS